Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes

MLA

Axel Haupt, et al. “Non-Alcoholic Fatty Liver Disease (NAFLD) Prevalence and Its Metabolic Associations in Patients with Type 1 Diabetes and Type 2 Diabetes.” Diabetes, Obesitymetabolism, vol. 19, no. 11, Dec. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c629844c99a003a8c827624df44e81b7&authtype=sso&custid=ns315887.

APA

Axel Haupt, Mark L. Hartman, Juliana M. Bue-Valleskey, Shuyu Zhang, Kenneth Cusi, Arun J. Sanyal, & Byron J. Hoogwerf. (2016). Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes. Diabetes, Obesitymetabolism, 19(11).

Chicago

Axel Haupt, Mark L. Hartman, Juliana M. Bue-Valleskey, Shuyu Zhang, Kenneth Cusi, Arun J. Sanyal, and Byron J. Hoogwerf. 2016. “Non-Alcoholic Fatty Liver Disease (NAFLD) Prevalence and Its Metabolic Associations in Patients with Type 1 Diabetes and Type 2 Diabetes.” Diabetes, Obesitymetabolism 19 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c629844c99a003a8c827624df44e81b7&authtype=sso&custid=ns315887.